U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07174713) titled 'REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)' on Aug. 08.
Brief Summary: In this program of research, the investigators aim to answer the question: In patients with asthma aged 18-80, how do the lung airways and vessels respond to biologic therapy and what role does age and asthma duration have in this response? While about 4.6 million Canadians live with asthma, ~5-10% of patients have severe asthma meaning that multiple inhaled and systemic oral corticosteroid treatments have failed to improve symptoms and exacerbations, leading to lost work and school days and substantially diminished ability to parti...